Showing results (161-170 of 173) with videos related to

Sort By:
Pageof 18
Gastroenterology|March 20, 2025
From "Burnt-Out" to "Burning-Out": Capturing Liver Fat Loss in Patients With Advanced Metabolic Dysfunction-Associated Steatotic Liver Disease From a Dynamic PerspectiveWen-Yue Liu, Shanshan Huang, Hongsheng Ji, et al.
Gut|August 1, 2024
Long-term liver-related outcomes and liver stiffness progression of statin usage in steatotic liver diseaseXiao-Dong Zhou, Seung Up Kim, Terry Cheuk-Fung Yip, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 8, 2026
Progression of Liver Fibrosis and Liver-Related Event Risk in MASLD at High Cardiovascular RiskXiao-Dong Zhou, Qin-Fen Chen, Seung Up Kim, et al.
Gut|June 20, 2025
Non-invasive risk-based surveillance of hepatocellular carcinoma in patients with metabolic dysfunction-associated steatotic liver diseaseJimmy Che-To Lai, Boyu Yang, Hye Won Lee, et al.
Hepatology International|June 27, 2026
APASL clinical practice guidelines on the management of chronic hepatitis B infection: a 2026 updateHong You, Rakhi Maiwall, Jing Chen, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 1, 2026
ONE-YEAR CHANGES IN LSM, BUT NOT IN ALT AND CAP, PREDICT LONG-TERM LIVER OUTCOMES IN PATIENTS WITH MASLDGrazia Pennisi, Giuseppe Infantino, Gabriele Di Maria, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 11, 2025
A Novel Risk Prediction Model for Hepatocellular Carcinoma in MASLD: A Multinational, Multicenter Cohort StudyHo Soo Chun, Minjong Lee, Hye Ah Lee, et al.
Hepatology (Baltimore, Md.)|December 16, 2025
Cardiovascular-Kidney-Metabolic syndrome and the risk of liver fibrosis progression and liver-related events in MASLDXiao-Dong Zhou, Qin-Fen Chen, Qiong-Yue Fan, et al.
Gut|March 30, 2026
Two-step clinical care pathway to predict MASLD-related advanced fibrosis and long-term outcomes in type 2 diabetesYuping Chen, Bingtian Dong, Xinrui Jin, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 3, 2024
acFibroMASH Index for the Diagnosis of Fibrotic MASH and Prediction of Liver-related Events: An International Multicenter StudyGong Feng, Ferenc E Mózes, Dong Ji, et al.
Pageof 18